Stockscreener 앱 받기
1.59
4.61%
0.07
시간 외 거래:
1.59
전일 마감가:
$1.52
열려 있는:
$1.5
하루 거래량:
131.80K
Relative Volume:
0.83
시가총액:
$49.61M
수익:
$1.82M
순이익/손실:
$-267.63M
주가수익비율:
-0.0789
EPS:
-20.1639
순현금흐름:
$-50.53M
1주 성능:
-14.97%
1개월 성능:
-28.05%
6개월 성능:
-48.54%
1년 성능:
-91.99%
1일 변동 폭
$1.40
$1.63
1주일 범위
$1.40
$1.95
52주 변동 폭
$1.40
$21.23
Cibus Inc Stock (CBUS) Company Profile
명칭
Cibus Inc
전화
(858) 450-0008
주소
6455 NANCY RIDGE DRIVE, SAN DIEGO
CBUS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBUS
Cibus Inc
|
1.59 | 49.61M | 1.82M | -267.63M | -50.53M | -20.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.56 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.78 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
550.00 | 33.54B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.95 | 30.15B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
220.54 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Cibus Inc Stock (CBUS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-07-29 | 개시 | Alliance Global Partners | Buy |
| 2024-07-19 | 재개 | Canaccord Genuity | Buy |
| 2023-10-09 | 개시 | H.C. Wainwright | Buy |
| 2023-07-19 | 재개 | Canaccord Genuity | Buy |
Cibus Inc 주식(CBUS)의 최신 뉴스
Canaccord cuts Cibus stock target to $18, maintains buy rating - MSN
Levi & Korsinsky Announces an Investigation on Behalf of Cibus, Inc. (CBUS) Shareholders Who May Have Been Affected by Fraud - ACCESS Newswire
Corient Private Wealth LLC Sells 60,000 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Charles Schwab Investment Management Inc. Sells 7,726 Shares of Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus stock plunges to 52-week low, hits $1.8 amid sharp decline - Investing.com Australia
Cibus stock plunges to 52-week low, hits $1.8 amid sharp decline By Investing.com - Investing.com South Africa
Research Analysts Offer Predictions for Cibus Q1 Earnings - MarketBeat
HC Wainwright Reiterates Buy Rating for Cibus (NASDAQ:CBUS) - MarketBeat
Cibus director Prante Gerhard sells $2,875 in stock - MSN
Cibus outlines advanced gene editing initiatives with potential revenue milestones by 2026 - MSN
What is HC Wainwright’s Forecast for Cibus Q1 Earnings? - Defense World
Cibus (NASDAQ:CBUS) Earns Buy Rating from HC Wainwright - Defense World
Cibus, Inc. (NASDAQ:CBUS) Q4 2024 Earnings Call Transcript - Insider Monkey
Cibus, Inc. Earnings Call: Strategic Progress Amid Challenges - TipRanks
Cibus (NASDAQ:CBUS) Posts Earnings Results, Misses Estimates By $0.19 EPS - MarketBeat
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Insights - Yahoo Finance
Cibus Reports Fourth Quarter Financial Results and Provides Business Update - The Manila Times
Cibus Inc (CBUS) Q4 2024 Earnings Call Highlights: Strategic Adv - GuruFocus
Cibus, Inc. Reports Progress in Gene Editing and Financial Results - TipRanks
Cibus: Q4 Earnings Snapshot - mySA
Earnings call transcript: Cibus Inc. Q4 2024 focuses on innovation and cost-saving - Investing.com India
Cibus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cibus: Q4 Earnings Snapshot -March 20, 2025 at 06:00 pm EDT - MarketScreener
Cibus Inc. (CBUS) reports earnings - Quartz
Cibus Reports Fourth Quarter Financial Results And Provides Business Update -March 20, 2025 at 04:54 pm EDT - Marketscreener.com
Cibus, Inc. SEC 10-K Report - TradingView
Cibus (CBUS) Expected to Announce Earnings on Thursday - The AM Reporter
Cibus Welcomes the European Union's Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward - The Manila Times
Cibus, Inc. Supports EU Legislation Advancing New Genomic Techniques for Sustainable Agriculture - Nasdaq
Cibus Welcomes the European Union’s Progress as Legislation for New Genomic Techniques to Boost Innovation and Sustainability Moves Forward - TradingView
Cibus director Gerhard Prante sells shares worth $6,106 - MSN
Cibus (CBUS) to Release Quarterly Earnings on Thursday - MarketBeat
Cibus (CBUS) Projected to Post Earnings on Thursday - Defense World
Cibus Achieves Another Milestone for a Durable White Mold Resistance Trait in Canola - CropLife
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close and Host Conference Call - The Manila Times
Cibus, Inc. to Report Fourth Quarter 2024 Financial Results on March 20, 2025 - Nasdaq
Cibus to Report Fourth Quarter 2024 Financial Results on March 20, 2025 After the Market Close - Bluefield Daily Telegraph
Agricultural Biotech Leader Cibus Sets Q4 Earnings Date: Key Gene Editing Updates Expected - StockTitan
13,000 Shares in Cibus, Inc. (NASDAQ:CBUS) Purchased by IFP Advisors Inc - Defense World
Cibus Inc (CBUS) Shares Soar Above 1-Year High - The News Heater
Cibus’s Strategic Advancements and Leadership Transition Drive Buy Rating - TipRanks
Cibus' Achieves Another Milestone for a Durable White Mold (Sclerotinia) Resistance Trait in Canola - The Manila Times
Can Cibus' Gene-Edited Canola Traits Revolutionize Crop Disease Management? - StockTitan
Cibus Announces Leadership Transition and CEO Succession Plan - Seed World
Cibus Inc (CBUS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.48%
자본화:
|
볼륨(24시간):